Fernando Delgado Acosta-rekin lankidetzan egindako argitalpenak (6)

2024

  1. Statistical analysis plan for the multicenter, open, randomized controlled clinical trial to assess the efficacy and safety of intravenous tirofiban vs aspirin in acute ischemic stroke due to tandem lesion, undergoing recanalization therapy by endovascular treatment (ATILA trial)

    Trials, Vol. 25, Núm. 1

2023

  1. Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trial

    The Lancet Neurology, Vol. 22, Núm. 2, pp. 137-146

  2. Safety and efficacy of tirofiban in acute ischemic stroke due to tandem lesions undergoing mechanical thrombectomy: A multicenter randomized clinical trial (ATILA) protocol

    European Stroke Journal, Vol. 8, Núm. 1, pp. 380-386

2020

  1. Circulating microRNA after autologous bone marrow mononuclear cell (BM-MNC) injection in patients with ischemic stroke

    Journal of Investigative Medicine, Vol. 68, Núm. 3, pp. 807-810

  2. The value of transcranial doppler sonography in hyperperfusion syndrome after carotid artery stenting: A nationwide prospective study

    Journal of Stroke

2019

  1. Clinical Predictors of Hyperperfusion Syndrome Following Carotid Stenting: Results From a National Prospective Multicenter Study

    JACC: Cardiovascular Interventions, Vol. 12, Núm. 9, pp. 873-882